• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放疗抵抗性乳腺癌细胞中细胞外腺苷增加通过A2AR-Akt-β-连环蛋白信号传导增强肿瘤进展。

Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling.

作者信息

Jin Hana, Lee Jong-Sil, Kim Dong-Chul, Ko Young-Shin, Lee Gyeong-Won, Kim Hye-Jung

机构信息

Department of Pharmacology, College of Medicine, Institute of Health Sciences, Gyeongsang National University, Jinju 52727, Korea.

Department of Pathology, College of Medicine, Institute of Health Sciences, Gyeongsang National University Hospital, Gyeongsang National University, Jinju 52727, Korea.

出版信息

Cancers (Basel). 2021 Apr 27;13(9):2105. doi: 10.3390/cancers13092105.

DOI:10.3390/cancers13092105
PMID:33925516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8123845/
Abstract

Recently, we found that the expressions of adenosine (ADO) receptors A2AR and A2BR and the ectonucleotidase CD73 which is needed for the conversion of adenosine triphosphate (ATP) to adenosine diphosphate (ADP) and the extracellular ADO level are increased in TNBC MDA-MB-231 cells and RT-R-MDA-MB-231 cells compared to normal cells or non-TNBC cells. The expression of A2AR, but not A2BR, is significantly upregulated in breast cancer tissues, especially TNBC tissues, compared to normal epithelial tissues. Therefore, we further investigated the role of ADO-activated A2AR and its signaling pathway in the progression of RT-R-TNBC. ADO treatment induced MDA-MB-231 cell proliferation, colony formation, and invasion, which were enhanced in RT-R-MDA-MB-231 cells in an A2AR-dependent manner. A2AR activation by ADO induced AKT phosphorylation and then β-catenin, Snail, and vimentin expression, and these effects were abolished by A2AR-siRNA transfection. In an in vivo animal study, compared to 4T1-injected mice, RT-R-4T1-injected mice exhibited significantly increased tumor growth and lung metastasis, which were decreased by A2AR-knockdown. The upregulation of phospho-AKT, β-catenin, Snail, and vimentin expression in mice injected with RT-R-4T1 cells was also attenuated in mice injected with RT-R-4T1-A2AR-shRNA cells. These results suggest that A2AR is significantly upregulated in BC tissues, especially TNBC tissues, and ADO-mediated A2AR activation is involved in RT-R-TNBC invasion and metastasis through the AKT-β-catenin pathway.

摘要

最近,我们发现,与正常细胞或非三阴性乳腺癌(TNBC)细胞相比,TNBC的MDA-MB-231细胞和放疗抵抗性(RT-R)的MDA-MB-231细胞中,腺苷(ADO)受体A2AR和A2BR以及将三磷酸腺苷(ATP)转化为二磷酸腺苷(ADP)所需的胞外核苷酸酶CD73的表达,以及细胞外ADO水平均升高。与正常上皮组织相比,乳腺癌组织尤其是TNBC组织中,A2AR而非A2BR的表达显著上调。因此,我们进一步研究了ADO激活的A2AR及其信号通路在放疗抵抗性TNBC进展中的作用。ADO处理诱导MDA-MB-231细胞增殖、集落形成和侵袭,而在RT-R-MDA-MB-231细胞中这些作用以A2AR依赖的方式增强。ADO激活A2AR诱导AKT磷酸化,进而诱导β-连环蛋白、Snail和波形蛋白表达,而这些作用可被A2AR-siRNA转染消除。在一项体内动物研究中,与注射4T1细胞的小鼠相比,注射RT-R-4T1细胞的小鼠肿瘤生长和肺转移显著增加,而A2AR基因敲低可使其降低。注射RT-R-4T1细胞的小鼠中磷酸化AKT、β-连环蛋白、Snail和波形蛋白表达的上调,在注射RT-R-4T1-A2AR-shRNA细胞的小鼠中也减弱。这些结果表明,A2AR在乳腺癌组织尤其是TNBC组织中显著上调,且ADO介导的A2AR激活通过AKT-β-连环蛋白途径参与放疗抵抗性TNBC的侵袭和转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbc/8123845/9dcbca8e12b9/cancers-13-02105-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbc/8123845/1a9340f6f3e3/cancers-13-02105-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbc/8123845/43728c3c39ee/cancers-13-02105-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbc/8123845/e270c971e854/cancers-13-02105-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbc/8123845/ccf445dd432c/cancers-13-02105-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbc/8123845/7a3974bc9b5e/cancers-13-02105-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbc/8123845/9dcbca8e12b9/cancers-13-02105-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbc/8123845/1a9340f6f3e3/cancers-13-02105-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbc/8123845/43728c3c39ee/cancers-13-02105-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbc/8123845/e270c971e854/cancers-13-02105-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbc/8123845/ccf445dd432c/cancers-13-02105-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbc/8123845/7a3974bc9b5e/cancers-13-02105-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbc/8123845/9dcbca8e12b9/cancers-13-02105-g006.jpg

相似文献

1
Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling.放疗抵抗性乳腺癌细胞中细胞外腺苷增加通过A2AR-Akt-β-连环蛋白信号传导增强肿瘤进展。
Cancers (Basel). 2021 Apr 27;13(9):2105. doi: 10.3390/cancers13092105.
2
ESM-1 Overexpression is Involved in Increased Tumorigenesis of Radiotherapy-Resistant Breast Cancer Cells.内皮细胞特异性分子-1过表达与放疗抗性乳腺癌细胞的肿瘤发生增加有关。
Cancers (Basel). 2020 May 26;12(6):1363. doi: 10.3390/cancers12061363.
3
Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.紫草素通过糖原合酶激酶 3β 调控的β-连环蛋白信号抑制抑制作用逆转上皮间质转化,从而抑制三阴性乳腺癌细胞转移。
Biochem Pharmacol. 2019 Aug;166:33-45. doi: 10.1016/j.bcp.2019.05.001. Epub 2019 May 6.
4
Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.通过 ROS 介导的凋亡,CoQ0 的抗 EMT 特性归因于 PI3K/AKT/NFKB/MMP-9 信号通路。
J Exp Clin Cancer Res. 2019 May 8;38(1):186. doi: 10.1186/s13046-019-1196-x.
5
Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/mTOR/PI3K signaling.lncRNA Aim表达降低主要通过激活Wnt/β-连环蛋白/mTOR/PI3K信号通路增强三阴性乳腺癌细胞的恶性侵袭。
Pharmazie. 2017 Oct 1;72(10):599-603. doi: 10.1691/ph.2017.7547.
6
Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.芳烃受体/细胞色素P450 1A1途径通过抑制PTEN以及激活β-连环蛋白和Akt介导乳腺癌干细胞的扩增。
Mol Cancer. 2017 Jan 19;16(1):14. doi: 10.1186/s12943-016-0570-y.
7
Polyphenols Extracted from L. Exhibit Anti-Cancer Effects on Radio-Resistant MDA-MB-231 Human Breast Cancer Cells by Suppressing Stem Cell Phenotype, β-Catenin, and MMP-9.从 L.中提取的多酚通过抑制干细胞表型、β-连环蛋白和 MMP-9 对耐辐射 MDA-MB-231 人乳腺癌细胞发挥抗癌作用。
Molecules. 2020 Apr 21;25(8):1916. doi: 10.3390/molecules25081916.
8
Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts.增强或沉默心脏成纤维细胞中腺苷A2b受体的功能效应。
Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2478-86. doi: 10.1152/ajpheart.00217.2004. Epub 2004 Jul 29.
9
A2a adenosine receptor agonist improves endoplasmic reticulum stress in MIN6 cell line through protein kinase A/ protein kinase B/ Cyclic adenosine monophosphate response element-binding protein/ and Growth Arrest And DNA-Damage-Inducible 34/ eukaryotic Initiation Factor 2α pathways.A2a 腺苷受体激动剂通过蛋白激酶 A/蛋白激酶 B/环腺苷酸反应元件结合蛋白/生长停滞和 DNA 损伤诱导蛋白 34/真核起始因子 2α通路改善 MIN6 细胞系内质网应激。
J Cell Physiol. 2019 Jul;234(7):10500-10511. doi: 10.1002/jcp.27719. Epub 2018 Nov 11.
10
Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway.细胞外 5'-核苷酸酶(CD73)通过 AKT/GSK-3β/β-连环蛋白/细胞周期蛋白 D1 信号通路促进人乳腺癌细胞的生长。
Int J Cancer. 2018 Mar 1;142(5):959-967. doi: 10.1002/ijc.31112. Epub 2017 Oct 31.

引用本文的文献

1
Fluorinated small molecule derivatives in cancer immunotherapy: emerging frontiers and therapeutic potential.癌症免疫治疗中的氟化小分子衍生物:新兴前沿与治疗潜力
Front Immunol. 2025 Jul 18;16:1622091. doi: 10.3389/fimmu.2025.1622091. eCollection 2025.
2
NOTCH1 combined with chemotherapy synergistically inhibits triple-negative breast cancer.NOTCH1与化疗联合使用可协同抑制三阴性乳腺癌。
World J Clin Oncol. 2025 Jun 24;16(6):106197. doi: 10.5306/wjco.v16.i6.106197.
3
Insights from Clinical Trials on A Adenosine Receptor Antagonists for Cancer Treatment.

本文引用的文献

1
Targeting CD73 to augment cancer immunotherapy.靶向 CD73 以增强癌症免疫疗法。
Curr Opin Pharmacol. 2020 Aug;53:66-76. doi: 10.1016/j.coph.2020.07.001. Epub 2020 Aug 7.
2
Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K-AKT-mTOR signaling.腺苷与腺苷受体 A2a 的相互作用通过增强 PI3K-AKT-mTOR 信号通路促进胃癌转移。
Mol Biol Cell. 2019 Sep 1;30(19):2527-2534. doi: 10.1091/mbc.E19-03-0136. Epub 2019 Jul 24.
3
Radioresistant breast cancer cells exhibit increased resistance to chemotherapy and enhanced invasive properties due to cancer stem cells.
A腺苷受体拮抗剂用于癌症治疗的临床试验见解。
ACS Pharmacol Transl Sci. 2025 May 2;8(6):1498-1512. doi: 10.1021/acsptsci.5c00057. eCollection 2025 Jun 13.
4
Discovery of a potent, selective, and tumor-suppressing antibody antagonist of adenosine A2A receptor.发现一种有效的、选择性的、肿瘤抑制的腺苷 A2A 受体抗体拮抗剂。
PLoS One. 2024 Jun 5;19(6):e0301223. doi: 10.1371/journal.pone.0301223. eCollection 2024.
5
Adenosine receptors in breast cancer.乳腺癌中的腺苷受体。
Mol Biol Rep. 2024 Mar 29;51(1):464. doi: 10.1007/s11033-024-09382-z.
6
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment.cAMP-PKA/EPAC 信号转导与癌症:肿瘤微环境中的相互作用。
J Hematol Oncol. 2024 Jan 17;17(1):5. doi: 10.1186/s13045-024-01524-x.
7
Role of adenosine A2a receptor in cancers and autoimmune diseases.腺苷 A2a 受体在癌症和自身免疫性疾病中的作用。
Immun Inflamm Dis. 2023 Apr;11(4):e826. doi: 10.1002/iid3.826.
8
CD73: Friend or Foe in Lung Injury.CD73:肺损伤的友敌。
Int J Mol Sci. 2023 Mar 14;24(6):5545. doi: 10.3390/ijms24065545.
9
Emerging roles of purinergic signaling in anti-cancer therapy resistance.嘌呤能信号在抗癌治疗耐药性中的新作用。
Front Cell Dev Biol. 2022 Sep 19;10:1006384. doi: 10.3389/fcell.2022.1006384. eCollection 2022.
10
P2YR-Mediated PAK1 Activation Is Involved in ESM-1 Overexpression in RT-R-MDA-MB-231 through FoxO1 Regulation.P2YR介导的PAK1激活通过FoxO1调控参与RT-R-MDA-MB-231细胞中ESM-1的过表达。
Cancers (Basel). 2022 Aug 26;14(17):4124. doi: 10.3390/cancers14174124.
耐辐射乳腺癌细胞由于癌症干细胞的存在而表现出对化疗的更高抗性和增强的侵袭特性。
Oncol Rep. 2018 Dec;40(6):3752-3762. doi: 10.3892/or.2018.6714. Epub 2018 Sep 18.
4
P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer.P2Y2R 介导体细胞焦亡激活参与乳腺癌细胞的肿瘤进展和放疗抵抗型乳腺癌的发生。
Int J Oncol. 2018 Nov;53(5):1953-1966. doi: 10.3892/ijo.2018.4552. Epub 2018 Sep 4.
5
Targeting adenosine for cancer immunotherapy.针对癌症免疫疗法的腺苷靶点。
J Immunother Cancer. 2018 Jun 18;6(1):57. doi: 10.1186/s40425-018-0360-8.
6
The role of NRAGE subcellular location and epithelial-mesenchymal transition on radiation resistance of esophageal carcinoma cell.NRAGE亚细胞定位及上皮-间质转化在食管癌细胞辐射抗性中的作用
J Cancer Res Ther. 2018 Jan;14(1):46-51. doi: 10.4103/jcrt.JCRT_687_17.
7
Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance.上皮-间质转化(EMT)特征及PARP-1在前列腺癌放射抗性中的预测价值
Prostate. 2017 Dec;77(16):1583-1591. doi: 10.1002/pros.23435. Epub 2017 Oct 23.
8
Extracellular nucleosides and nucleotides as immunomodulators.细胞外核苷和核苷酸作为免疫调节剂。
Immunol Rev. 2017 Nov;280(1):83-92. doi: 10.1111/imr.12571.
9
Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.长链非编码RNA(LncRNA)HOXA11-AS通过调控上皮-间质转化促进乳腺癌侵袭和转移。
Med Sci Monit. 2017 Jul 13;23:3393-3403. doi: 10.12659/msm.904892.
10
Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.长链非编码RNA SPRY4-IT1表达降低部分通过影响上皮-间质转化促进卵巢癌细胞转移。
Tumour Biol. 2017 Jul;39(7):1010428317709129. doi: 10.1177/1010428317709129.